Improvement of glycemic control in patients with type 2 diabetes mellitus
Who uses it
Adults
Adult dosage
One tablet may be administered once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly.
If the eGFR is 45 mL/min/1.73m2 or greater, no dosage adjustment based on renal function is required.
Do not administer this drug if the eGFR is less than 45 mL/min/1.73m2.
Improvement of glycemic control in patients with type 2 diabetes mellitus
View approved original textHide original text
This medication is used to assist patients with type 2 diabetes in controlling blood sugar levels when taken in combination with sitagliptin and pioglitazone. Taking this medication along with dietary and exercise therapy enhances blood sugar management. It helps maintain stable blood sugar levels, supporting a healthy lifestyle.
Dosage and Administration
Adult dosage
One tablet may be administered once daily, with or without food, to patients with type 2 diabetes mellitus who are receiving sitagliptin 100mg and pioglitazone 15mg or 30mg concomitantly.
If the eGFR is 45 mL/min/1.73m2 or greater, no dosage adjustment based on renal function is required.
Do not administer this drug if the eGFR is less than 45 mL/min/1.73m2.
Precautions
This medication contains sitagliptin and pioglitazone and is used for diabetes treatment.
Sitagliptin can rarely cause serious allergic reactions. Therefore, if symptoms such as rash, difficulty breathing, or swelling of the face or tongue occur within three months of administration, the medication should be discontinued immediately and medical consultation should be sought.
Additionally, sitagliptin may cause acute pancreatitis, so if symptoms like upper abdominal pain, vomiting, or loss of appetite occur, medical attention should be sought immediately.
Pioglitazone may cause fluid retention, exacerbating heart failure, so patients with heart failure or a history of heart failure should not take this medication.
When taking pioglitazone, watch for symptoms of swelling or shortness of breath, and consult a doctor if these symptoms occur.
This medication should not be administered to patients with bladder cancer or a history of bladder cancer, and immediate medical attention should be sought if gross hematuria or urination issues arise.
Patients with severely impaired kidney or liver function must consult a doctor before taking this medication, and dosage adjustment may be necessary if kidney function is decreased.
It is safest for women who are pregnant or could become pregnant to avoid taking this medication.
While taking this medication, signs of hypoglycemia (dizziness, cold sweat, severe fatigue, etc.) may occur, so caution is advised, especially when taken with other diabetes medications.
Furthermore, this medication may cause side effects such as headache, upper respiratory tract infections, edema, weight gain, dyspepsia, etc. Therefore, if any unusual symptoms persist, medical consultation should be sought.
Prior to taking this medication, it is essential to inform the doctor of your medical history and any medications currently being taken, and to regularly undergo blood tests and liver function tests.
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a tightly-closed container to prevent air and moisture from entering, at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the drug's effectiveness for longer periods.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety. Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.